Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Income Statement [Abstract]
Revenue	$ 739,983	$ 602,581
Costs and expenses:
Cost of revenue	181,091	170,926
Research and development	280,275	266,346
Sales and marketing	226,289	201,131
General and administrative	106,744	207,864
Total costs and expenses	794,399	846,267
Loss from operations	(54,416)	(243,686)
Interest income (expense), net	31,266	24,901
Other income (expense), net	(4,526)	322
Loss before benefit from income taxes	(27,676)	(218,463)
Benefit from income taxes	(2,864)	(9,884)
Net loss	$ (24,812)	$ (208,579)
Net loss per share, basic (in dollars per share)	$ (0.04)	$ (0.31)
Net loss per share, diluted (in dollars per share)	$ (0.04)	$ (0.31)
Weighted-average shares used in computing net loss per share, basic (in shares)	678,819	681,140
Weighted-average shares used in computing net loss per share, diluted (in shares)	678,819	681,140